DAIC

JULY 29, 2024

Magenta's technology stands at the forefront of innovation in the MCS field and has the potential to significantly improve outcomes in patients with severe cardiovascular conditions,” said Eric Snyder, Partner, Venture Investments, Novo Holdings US. The financing will be used to advance the company’s U.S. Magenta Medical Ltd.

Cardiogenic Shock 105

Cardiogenic Shock Blood Pressure Technology Aortic valve 105

Stroke Journal

DECEMBER 15, 2023

Based on current evidence, we advocate for the widespread adoption of an early bundle of care for patients with intracerebral hemorrhage focused on time-based metrics for blood pressure control and emergency reversal of anticoagulation, with the goal of optimizing the benefit of these already widely used interventions.

Best Practices 75

Best Practices Hemorrhage Blood Pressure Innovation 75

MIBHS

JANUARY 31, 2025

By understanding patterns in heart rate, blood pressure, and oxygen levels, surgeons can tailor procedures to the individuals needs. By embracing this innovative approach, you can pave the way for a healthier heart and a brighter future. Wearable technology can support these advanced procedures in several ways: 1.

Heart Rhythm 52

Heart Rhythm Technology AFIB Exercise 52

Wellnest

DECEMBER 18, 2023

These groundbreaking developments offer a paradigm shift in the management of resistant hypertension, especially when it is extremely difficult to achieve blood pressure control through conventional means, such as lifestyle modifications and various drug therapies.

Hypertension 52

Hypertension Blood Pressure Ablation Reimbursement 52

Cardiometabolic Health Congress

AUGUST 14, 2024

Harnessing Collaborative Innovation to Combat Cardiometabolic Risk Building on the foundation in Part 1 , explore real-world examples of how creative partnerships transform cardiorenal metabolic risk management. It further exemplifies the patient education and empowerment strategies.

Education 52

Education Innovation Reimbursement Cardiovascular Disease 52

DAIC

FEBRUARY 29, 2024

ET Murphy Ballroom 4 Comparison of an "Inclisiran First" Strategy with Usual Care in Patients With Atherosclerotic Cardiovascular Disease: Results From the VICTORION-INITIATE Randomized Trial Targeting Weight Loss to Personalize the Prevention of Type 2 Diabetes Once-weekly Semaglutide in Patients with Heart Failure With Preserved Ejection Fraction, (..)

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

GEMMS

MAY 22, 2024

In this article, we will explore the top 10 trends shaping the future of cardiovascular medicine, highlighting the innovative technologies and approaches that are revolutionizing the field. Traditional tools like stethoscopes, blood pressure gauges, and electrocardiograms (ECG) are fundamental for standard diagnostic practices.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

Cardiometabolic Health Congress

AUGUST 14, 2024

This October, we gather for the largest and most innovative cardiometabolic event, honoring Dr. Bakris’ profound impact on our community. With his support, CMHC has championed a vision of a brighter future for clinicians, patients, and the entire healthcare sector. When I heard of his passing, I felt quite sad.

CME 72

CME Education Diabetes Innovation 72

Circulation: Cardiovascular Quality & Outcomes

MARCH 26, 2025

Building upon facilitators and addressing core challenges are essential for expansion of innovative hypertension care delivery programs to improve patient outcomes at scale. Key challenges include nonlicensed navigator training and communication clarity about program structure.

Hypertension 40

Hypertension Blood Pressure Chronic Disease Innovation 40

Open Heart

NOVEMBER 4, 2022

We; therefore, evaluated the efficacy of an existing dedicated HFpEF clinic to find innovative ways to design a more comprehensive model tailored to the modern era of HFpEF. Methods A single-centre retrospective analysis of 202 HFpEF outpatients was performed over 12 months before the COVID-19 pandemic.

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure COVID-19 Outpatient 52

Circulation

NOVEMBER 11, 2024

Self-Measured Blood Pressure (SMBP) monitoring tools and the AMA MAP™ framework, along with capacity-building resources were deemed effective approaches. Barriers that hindered CCL optimization include staffing shortages, low health literacy, lack of funding, an absence of leadership buy-in, and low patient engagement.

Blood Pressure 40

Blood Pressure Public Health Hypertension Innovation 40

SoftCath

OCTOBER 31, 2021

So, let’s unwind how the innovations in cath lab software are reshaping the method of cardiovascular care post-Covid-19. All of this resulted in the need for better and innovative cardiac care strategies that ensure better patient engagement and trust in digital medical infrastructure.

COVID-19 52

COVID-19 Innovation Cardiac Rehabilitation Cardiovascular Disease 52

Dr. S. Venkatesan MD

JULY 1, 2024

The innovators and engineers of new-age mechanical assist systems could learn a few crucial insights from these unique and humble animal beings. Maloney, Duncan Mitchell The origin of mean arterial and jugular venous blood pressures in giraffes The Journal of Experimental Biology 209, 2515-2524 2.Aalkjær Reference 1.

Cardiomyopathy 52

Cardiomyopathy Aortic valve Aortic Blood Pressure 52

Wellnest

JANUARY 23, 2024

Nicotine and other harmful substances present in tobacco can lead to constriction of blood vessels, an increase in heart rate, and elevated blood pressure. Consumption of Tobacco and Cigarettes: The consumption of tobacco and cigarettes stands out as a significant risk factor for cardiac emergencies.

COVID-19 52

COVID-19 Cardiovascular Disease Risk Factors Blood Pressure 52

Vector Remote

APRIL 14, 2023

History & Future of Cardiac Remote Patient Monitoring Healthcare reforms fueled by government legislation and recent technological innovations have propelled cardiac remote patient monitoring to the forefront in the early 2020s, but the history of cardiac remote patient monitoring dates to more than half a century ago.

Pacemaker 52

Pacemaker Technology COVID-19 Arrhythmia 52

Frontiers in Cardiovascular Medicine

MARCH 27, 2025

WAKE UP can significantly impact CV prevention by involving innovative actions addressing a major public health need and by fostering complementary and synergistic actions. Participants will attend a baseline visit and follow-up visits at 6 and 12-months.

Ultrasound 40

Ultrasound Plaque Blood Pressure Public Health 40

DAIC

MAY 21, 2024

A new peer-reviewed study published in the Journal of the American Heart Association , JAHA, found that Hello Heart’s digital heart health program was associated with reductions in blood pressure (BP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and weight.

Blood Pressure 52

Blood Pressure Cholesterol Risk Factors BMI 52

DAIC

MAY 3, 2024

Clinical trials and innovative technology took center stage during the month of April, racking up some record number views. New Study Reveals 65 and Older Population Lowered Blood Pressure, Cholesterol and Weight Using Mobile Technology 2. Here is a look at what DAIC viewers were reading last month: 1.

Angioplasty 105

Angioplasty Blood Pressure Heart attacks Heart Attack 105

DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies."

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Kidney Disease Research 52

DAIC

JUNE 25, 2024

for one hundred years – with nearly half (48.6%) of all people over the age of 20 years old having some type of cardiovascular disease (CVD), including coronary heart disease, heart failure, stroke and, most notably, high blood pressure. According to the 2024 Heart Disease and Stroke Statistics: A Report of U.S.

Electrophysiology 105

Electrophysiology Hospital Aortic valve Heart Disease 105

DAIC

APRIL 1, 2024

Moreover, electrocardiograms, which record the electrical activity of the heart, and wearable devices can provide artificial intelligence (AI) the data it needs to spot possible cases of valvular heart disease via fluctuations in heart rate, blood pressure, blood oxygenation and other factors.

Technology 105

Technology Heart Disease Innovation Ultrasound 105

DAIC

JUNE 28, 2024

In fact, only 1% of health care research and innovation was invested in female-specific conditions outside of oncology, according to the most recent data available. [1] A lack of scientific knowledge, limited gender-specific medical training, and little investment in specific research and venture funding further exacerbate this disparity.

Cardiovascular Disease 105

Cardiovascular Disease Obesity Research Heart Disease 105

Circulation

NOVEMBER 11, 2024

The initial dose should be lowered depending on the level of the Ross score to avoid high peak concentrations and a potential drop in blood pressure. Background:Safe dosing in children with heart failure requires consideration of clinically relevant covariates.

Heart Failure 40

Heart Failure Innovation ACE Inhibitor Congenital Heart Disease 40

DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies."

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Research Academic 52

Cardiometabolic Health Congress

JULY 17, 2024

February 2024 FDA Approvals: Innovations in Cardiovascular Interventions XACT Carotid Stent System (Approved: 02/07/2024) This approval expands the indications to be used during a Transcarotid Artery Revascularization (TCAR) procedure to prevent future strokes.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Pediatrics 59

Hypertension Journal

FEBRUARY 21, 2024

Indeed, even though numerous drugs are available, achieving adequate blood pressure control remains a challenge, prompting recent interest in artificial intelligence. Hypertension, a leading cause of cardiovascular disease and premature death, remains incompletely understood despite extensive research.

Hypertension 45

Hypertension Blood Pressure Innovation Risk Factors 45

Wellnest

JULY 19, 2023

However, recent studies have observed that people below 40 are also experiencing heart attacks due to high blood pressure, cholesterol, diabetes, smoking, obesity, a sedentary lifestyle, and social and mental stress. Keep an eye on blood pressure. So, how do you recognize a heart attack? Maintain a nutritious diet.

Heart attacks 52

Heart attacks Heart Attack Blood Pressure Myocardial Infarction 52

Journal of the American Heart Association

FEBRUARY 23, 2024

Our previous study provided evidence for a novel blood pressure–regulating mechanism involving 4β‐hydroxycholesterol (4βHC), an agonist for liver X receptors, as a hypotensive factor.

Coronary Artery Disease 67

Coronary Artery Disease Sudden Cardiac Death Blood Pressure Diabetes 67

Cardiometabolic Health Congress

NOVEMBER 22, 2024

From breakthrough medications to innovative technologies, there is a lot for cardiometabolic clinicians professionals to celebrate. The study found reductions in the apnea-hypopnea index (AHI), inflammation markers, and systolic blood pressure, making it a promising dual-purpose medication for managing obesity-related complications.

Blood Pressure 59

Blood Pressure Obesity Preserved Ejection Fraction Coronary Artery Disease 59

DAIC

JANUARY 27, 2025

This national coverage analysis was initiated by CMS in response to Medtronic's request to support Medicare beneficiary access to the SymplicitySpyral renal denervation (RDN) system, used in the Symplicity blood pressure procedure. The Symplicity SpyralProcedure The Symplicity Spyral RDN system, approved by the U.S.

CMS 52

CMS Blood Pressure Medicare Hypertension 52

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Attendees, including hundreds of health professionals, gained access to the latest knowledge and developments in the field, from exclusive insights from one of the foremost authorities on atherosclerosis, Dr. Peter Libby, to innovations like new therapeutic agents and exciting advancements in renal protection.

CME 103

CME Obesity Heart Failure Biomarkers 103